Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1070-2017Class II

Human lgG4 Subclass Liquid Reagent Kits Human lgG1& lgG2 Antisera, lgG3 & 4 Latex reagent and lgG Antisera...

The Binding Site Group Ltd. / initiated 2014-09-11 / Terminated / root cause: manufacturing process

The Binding Site Group, Ltd. began a recall of Human lgG4 Subclass Liquid Reagent Kits Human lgG1& lgG2 Antisera, lgG3 & 4 Latex reagent and lgG Antisera for use on Hitachi 911/912/917 and Hitachi Modular P... on . FDA classified it as Class II and gives the reason as "Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1070-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
The Binding Site Group Ltd.
Product
Human lgG4 Subclass Liquid Reagent Kits Human lgG1& lgG2 Antisera, lgG3 & 4 Latex reagent and lgG Antisera for use on Hitachi 911/912/917 and Hitachi Modular P Product Code LK009.H/LK001.H This kit is intended for qualifying human IgG subclasses 1,2,3 and 4 immunoglobulins in serum on the Beckman Coulter AU series. Meaurement of these immunoglobulins ais in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents
Product code
CFN Method, Nephelometric, Immunoglobulins (G, A, M)
Reason for recall
Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
Binding Site sent an Important Information letter dated September 30, 2014, Customers were instructed to retain the notification for records and additional instructions with the firm stating they were updating the instructions for use. Customers with questions were advised to contact their Binding Site representative or [email protected].
Distribution
Worldwide Distribution - US including n FL, OH, TN, MN, NW, MI, CA. and Internationally to Canada, France, UK, Spain, Germany, Czech Republic, Belgium, Italy, Australia, Brazil, Chile, China, Costa Rica, Kuwait, New Zealand, Oman, Pakistan, Portugal, Sweded, Taiwan, and Turkey.
Product codes and lots
All lots.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1070-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1067-2017Class IITerminatedVoluntary: Firm initiated
Z-1068-2017Class IITerminatedVoluntary: Firm initiated
Z-1069-2017Class IITerminatedVoluntary: Firm initiated
Z-1070-2017Class IITerminatedVoluntary: Firm initiated
Z-1071-2017Class IITerminatedVoluntary: Firm initiated
Z-1072-2017Class IITerminatedVoluntary: Firm initiated
Z-1073-2017Class IITerminatedVoluntary: Firm initiated